Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome

Table 2

Univariable regression analysis of clinical and laboratory parameters associated with FGF19.

Variables	B	SE	value	95% CI
TBIL (μmol/L)	0.528	0.126	<0.001	0.271-0.785	0.346
DBIL (μmol/L)	0.423	0.100	<0.001	0.220-0.627	0.352
TBA (μmol/L)	0.479	0.116	<0.001	0.242-0.716	0.339
MELD score	0.724	0.190	0.001	0.336-1.111	0.318
Mayo risk score	2.011	0.608	0.002	0.769-3.253	0.267
Fibrosis stage	0.253	0.107	0.037	0.018-0.487	0.338